Live Breaking News & Updates on Js016

Stay informed with the latest breaking news from Js016 on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Js016 and stay connected to the pulse of your community

Junshi Biosciences: Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19

Etesevimab and bamlanivimab administered together is authorized for treatment of recently diagnosed, mild to moderate COVID-19 in patients who are high risk for progression to severe COVID-19More than

China , Guangzhou , Guangdong , Puerto-rico , Philippines , Shanghai , United-states , Hong-kong , Suzhou , Jiangsu , Beijing , Italy